Canakinumab Improves Patient-Reported Outcomes in Patients with Recurrent Fever Syndromes: Results from a Phase 3 Trial

被引：0
|
作者：
Lachmann, Helen [1 ,2 ]
Lauwerys, Bernard [3 ]
Miettunen, Paivi [4 ]
Kallinich, Tilmann [5 ]
Jansson, Annette [6 ]
Rosner, Itzhak
Manna, Raffaele [7 ]
Murias, Saramaria [8 ]
Savic, Sinisa [9 ]
Smeets, Serge [10 ]
De Benedetti, Fabrizio [11 ]
Simon, Anna [12 ]
机构：
[1] Royal Free Hosp, London, England
[2] UCL, London, England
[3] Catholic Univ Louvain, Brussels, Brussels Hoofds, Belgium
[4] Alberta Childrens Prov Gen Hosp, Calgary, ON, Canada
[5] Charite, Berlin, Germany
[6] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany
[7] Univ Cattolica Sacro Cuore, Rome, Lazio, Italy
[8] Univ Hosp La Paz, Madrid, Spain
[9] St James Univ Hosp, Leeds, W Yorkshire, England
[10] Novartis, Amsterdam, Netherlands
[11] Bambino Gesu Pediat Hosp, Rome, Italy
[12] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0802
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Incorporating patient-reported outcomes in a phase I clinical trial
    Qin, Rui
    Dueck, Amylou C.
    Satele, Daniel
    Molina, Julian
    Erlichman, Charles
    Basch, Ethan
    Sloan, Jeff
    QUALITY OF LIFE RESEARCH, 2013, 22
  • [32] Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study
    Navarini, Alexander A.
    Prinz, Joerg C.
    Morita, Akimichi
    Tsai, Tsen-Fang
    Viguier, Manuelle-Anne
    Li, Ling
    Thoma, Christian
    Sivalingam, Mogana
    Lebwohl, Mark G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (04) : 730 - 736
  • [33] Patients′ perspective on tolerability of dostarlimab in NSCLC: Patient-reported outcomes from the phase II PERLA trial
    Reck, M.
    Granados, A. L. O. Ortega
    de Marinis, F.
    Shen, Q.
    Boklage, S. H.
    Dabrowski, C.
    Cho, L.
    Meyers, O.
    ANNALS OF ONCOLOGY, 2023, 34
  • [34] Patients' perspective on tolerability of dostarlimab in NSCLC: patient-reported outcomes from the Phase II PERLA trial
    Reck, Martin
    Granados, Ana Laura Ortega
    de Marinis, Filippo
    Shen, Qin
    Boklage, Susan
    Dabrowski, Christine
    Cho, Lillian
    Meyers, Oren
    Griesinger, Frank
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 130 - 130
  • [35] Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
    Louis, Edouard
    Lofberg, Robert
    Reinisch, Walter
    Camez, Anne
    Yang, Mei
    Pollack, Paul F.
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez M.
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (01): : 34 - 43
  • [36] Bimekizumab Improves Patient-Reported Outcomes in Psoriatic Arthritis: 48-Week Results from a Phase 2b Study and Association Between Patient-Reported Outcomes and Disease Activity
    Gossec, Laure
    Mease, Philip
    Gottlieb, Alice
    Assudani, Deepak
    Coarse, Jason
    Ink, Barbara
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [37] Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial
    Krueger, GG
    Langley, RG
    Finlay, AY
    Griffiths, CEM
    Woolley, JM
    Lalla, D
    Jahreis, A
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (06) : 1192 - 1199
  • [38] IMPACT OF DONIDALORSEN ON PATIENT-REPORTED OUTCOMES: RESULTS FROM THE PHASE 3 OASIS-HAE STUDY
    Yarlas, A.
    Riedl, M.
    Bordone, L.
    Treadwell, S.
    Wang, S.
    Newman, K.
    Cohn, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S37 - S37
  • [39] Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis
    Revicki, Dennis A.
    Willian, Mary Kaye
    Menter, Alan
    Gordon, Kenneth B.
    Kimball, Alexa B.
    Leonardi, Craig L.
    Langley, Richard G.
    Kimel, Miriam
    Okun, Martin
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (06) : 341 - 350
  • [40] Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD AND TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
    De Benedetti, Fabrizio
    Anton, Jordi
    Ben-Chetrit, Eldad
    Calvo, Inmaculada
    Frenkel, Joost
    Gattorno, Marco
    Hoffman, Hal M.
    Kasapcopur, Ozgur
    Kone-Paut, Isabelle
    Lachmann, Helen
    Moutschen, Michel
    Ozen, Seza
    Quartier, Pierre
    Simon, Anna
    Zeft, Andrew
    Lheritier, Karine
    Speziale, Antonio
    Junge, Guido
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345